Sangamo Therapeutics
Richmond, California, United States · Biotechnology, Genetics, Health Care
Sangamo Therapeutics, Inc. is a genomic medicine company based in California.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Richmond, California, United States
- Employees
- 321
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Public (SGMOQ)
- Website
- www.sangamo.com
- Company page
Recent activity at Sangamo Therapeutics
- : SEC 8-K (7.01):
- : SEC 8-K (2.01): On September 17, 2026, Sangamo Therapeutics, Inc. completed the sale of its assets primarily related to the AAV gene therapy product candidate for Fabry disease, ST-920, to PTC Therapeutics, Inc. This transaction, finalized under Chapter 11 bankruptcy proceedings, involves total consideration of $111 million in cash at closing, plus up to $100 million in contingent consideration based on specified milestones. The Asset Purchase Agreement was dated August 25, 2026, and the sale was authorized by a Sale Order from the U.S. Bankruptcy Court. The completion of this sale marks a significant step for the Company as it continues operating under a debtor-in-possession status. The strategic implications include monetary relief for the company's liabilities amidst ongoing Chapter 11 proceedings.
- : SEC 8-K (2.01):
Employee benefit plans
Sangamo Therapeutics files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Sangamo Therapeutics: questions and answers
What does Sangamo Therapeutics do?
Sangamo Therapeutics, Inc. is a genomic medicine company based in California.
Where is Sangamo Therapeutics headquartered?
Sangamo Therapeutics is headquartered in Richmond, California, United States.
How many employees does Sangamo Therapeutics have?
Sangamo Therapeutics has about 321 employees.
What is the latest news on Sangamo Therapeutics?
On Oct 14, 2026, SEC 8-K (7.01):
Is Sangamo Therapeutics a public company?
Yes. Sangamo Therapeutics is publicly traded under the ticker SGMOQ.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy